Growth Metrics

Neogenomics (NEO) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to -$423.9 million.

  • Neogenomics' Retained Earnings fell 3654.87% to -$423.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$423.9 million, marking a year-over-year decrease of 3654.87%. This contributed to the annual value of -$325.8 million for FY2024, which is 3186.58% down from last year.
  • Latest data reveals that Neogenomics reported Retained Earnings of -$423.9 million as of Q3 2025, which was down 3654.87% from -$396.8 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Retained Earnings peaked at $47.3 million during Q2 2021, and registered a low of -$423.9 million during Q3 2025.
  • For the 5-year period, Neogenomics' Retained Earnings averaged around -$194.1 million, with its median value being -$214.2 million (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 28788.51% in 2021, then tumbled by 97223.16% in 2022.
  • Neogenomics' Retained Earnings (Quarter) stood at -$14.8 million in 2021, then crashed by 972.23% to -$159.1 million in 2022, then plummeted by 55.3% to -$247.1 million in 2023, then plummeted by 31.87% to -$325.8 million in 2024, then plummeted by 30.13% to -$423.9 million in 2025.
  • Its Retained Earnings was -$423.9 million in Q3 2025, compared to -$396.8 million in Q2 2025 and -$351.7 million in Q1 2025.